Literature DB >> 14656956

Hypersensitivity of the adrenal cortex to trophic and secretory effects of angiotensin II in Lyon genetically-hypertensive rats.

Frédérick Aguilar1, Ming Lo, Bruno Claustrat, José Maria Saez, Jean Sassard, Jacques Yuan Li.   

Abstract

In Lyon hypertensive (LH) rats, a model of low-renin genetic hypertension, we investigated adrenal sensitivity to angiotensin II in terms of angiotensin II receptor (AT1 and AT2 receptors) regulation, morphological changes, and aldosterone and corticosterone secretion. Twelve-week-old LH rats, compared with normotensive LN and LL rats, were either untreated or treated for 4 weeks with AT1 receptor antagonist irbesartan (50 mg/kg/d), angiotensin-converting enzyme inhibitor perindopril (3 mg/kg/d), or perindopril (3 mg/kg/d) plus angiotensin II infusion (200 ng/kg/min). At 16 weeks, untreated LH rats had high systolic blood pressure (P<0.05), low aldosterone (P<0.05), and increased corticosterone (P<0.05) plasma levels. AT1-receptor binding density in the zona glomerulosa was similar in the three strains. In LH rats, angiotensin II infusion increased the relative adrenal weight from 10.5+/-0.3 to 16.7+/-0.7 mg/100g (P<0.05), whereas this change was very modest in normotensive rats. Zona glomerulosa enlarged and plasma aldosterone increased after angiotensin II infusion in the 3 strains, but more markedly in LH versus normotensive rats (2.4- versus 1.3- and 1.6-fold, respectively; 20- versus 10-fold in normotensive rats, P<0.05). Surprisingly, after angiotensin II infusion, despite the absence of angiotensin II receptors in the three strains, the zona fasciculata-reticularis enlarged 1.5-fold and plasma corticosterone increased 1.7-fold only in LH rats (P<0.05), suggesting an indirect control of this compartment by angiotensin II. The hypertrophy and hypersecretory activity of both zona glomerulosa and zona fasciculata-reticularis in LH rats in response to angiotensin II point to the adrenal cortex as a pivotal tissue in the pathophysiology of hypertension in LH rats.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14656956     DOI: 10.1161/01.HYP.0000107194.44040.d4

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

1.  Blood pressure response to angiotensin II is enhanced in obese Zucker rats and is attributed to an aldosterone-dependent mechanism.

Authors:  Helge Müller-Fielitz; Margot Lau; Olaf Jöhren; Florian Stellmacher; Markus Schwaninger; Walter Raasch
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

2.  TASK-3 channel deletion in mice recapitulates low-renin essential hypertension.

Authors:  Nick A Guagliardo; Junlan Yao; Changlong Hu; Elaine M Schertz; David A Tyson; Robert M Carey; Douglas A Bayliss; Paula Q Barrett
Journal:  Hypertension       Date:  2012-04-09       Impact factor: 10.190

Review 3.  Opportunities and limitations of genetic analysis of hypertensive rat strains.

Authors:  Juan M Saavedra
Journal:  J Hypertens       Date:  2009-06       Impact factor: 4.844

4.  Implication of chromosome 13 on hypertension and associated disorders in Lyon hypertensive rats.

Authors:  Sophie Gilibert; Alain Bataillard; Juerg Nussberger; Jean Sassard; Anne E Kwitek
Journal:  J Hypertens       Date:  2009-06       Impact factor: 4.844

Review 5.  Signaling Interactions in the Adrenal Cortex.

Authors:  András Spät; László Hunyady; Gergő Szanda
Journal:  Front Endocrinol (Lausanne)       Date:  2016-02-29       Impact factor: 5.555

6.  Gene expression profiling following maternal deprivation: involvement of the brain Renin-Angiotensin system.

Authors:  Claudia Liebl; Markus Panhuysen; Benno Pütz; Dietrich Trümbach; Wolfgang Wurst; Jan M Deussing; Marianne B Müller; Mathias V Schmidt
Journal:  Front Mol Neurosci       Date:  2009-05-14       Impact factor: 5.639

7.  6A3-5/Osa2 is an early activated gene implicated in the control of vascular smooth muscle cell functions.

Authors:  Gwenaele Garin; Kazem Zibara; Frederick Aguilar; Ming Lo; Adam Hurlstone; Robin Poston; John L Mcgregor
Journal:  J Biomed Biotechnol       Date:  2006

8.  The combination of atenolol and amlodipine is better than their monotherapy for preventing end-organ damage in different types of hypertension in rats.

Authors:  Ping Han; Fu-Ming Shen; He-Hui Xie; Yuan-Yuan Chen; Chao-Yu Miao; Jawahar L Mehta; Jean Sassard; Ding-Feng Su
Journal:  J Cell Mol Med       Date:  2009-02-12       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.